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IS THERE NECESSARY TO PERFORM URETERECTOMY IN RENAL CELL
CARCINOMA TREATMENT
Hueih-Shing Hsu, Heng-Chang Chuang, Shyh-Chyi Chang, Hsu-Hsiang
Wang, I-Hung Shao. Division of Urology, Department of Surgery, Lotung
Pohai Hospital Yilan, Taiwan
Purpose: Radical nephrectomy is the standard surgical treatment of
localized renal cell carcinoma.
Is there necessary to perform ureterectomy at the same time? We chal-
lenge this question, because we have tow cases of renal cell carcinoma
received radical nephrectomy but recurrent tumor was found in the ureter
several years later.
Materials and Methods: This is a 79 years old man who received left
radical nephrectomy for renal cell carcinoma stage (T2N0M0) 4 years ago.
And he underwent hemodialysis for end stage renal disease for 5 years.
Gross hematuria was noted recently and CT scan showed left ureter tumor
in the remaining stump. Ureterectomy with bladder cuff was done and
pathology shoed transitional cell carcinoma stage T3NoMo.
Results: This is a 90 years old man who received left radical nephrectomy
for renal cell carcinoma (stage T3N0M0) 14 years ago. He suffered from
gross hematuria and CT showed left ureter tumor in the stump. Ureter-
ectomy with bladder cuff was done and pathology shoed renal cell carci-
noma stage T4N1Mo.
Conclusion: Renal cell carcinoma is not only existed in renal parenchyma
but also in collecting system. Transitional cell carcinomamay occured in the
remaining stump of ureter in uremia patient. So it is better to perform ure-
terectomy in uremia patient or the larger renal tumor closed to renal pelvis.
NDP033:
ACUTE URINARY RETENTION IN A MAN WITH PROSTATE CANCER STILL
ELIGIBLE FOR TRANSURETHRAL RESECTION OF PROSTATE
Chih-Te Lin, Chen-Pang Hou, Yu-Hsiang Lin, Ke-Hung Tsui, Phei-Lang
Chang, Chien-Lun Chen. Division of Urology, Department of Surgery,
Chang Gung Memorial Hospital at Linkou, Chang Gung University, College
of Medicine, Taoyuan, Taiwan
Purpose: To interrogate the outcome of transurethral resection of prostate
(TURP) in men with prostate cancer (PCa).
Materials and Methods: A total of 160 patients with prostate cancer un-
dergoing TURP for acute urinary retention (AUR) between 2001 and 2010
were retrospectively reviewed. Thirty-eight patients undergoing palliative
TURP (pTURP group) and the other 122 patients with newly diagnosed
prostate cancer received TURP (iTURP group) were compared. We also
included 9 patients with prostate cancer undergoing palliative cystostomy
without TURP (cystostomy group). The data, including preoperative char-
acteristics, perioperative morbidities and mortality were analyzed.
Results: Therewere no signiﬁcant differences between the 2 groups in age,
initial PSA (iPSA), operative time, incontinence rate, hospital stay or Foley
catheter duration. However, the prostate volume was higher in iTURP
group (49.31± 25.57gm) than in pTURP group (39.29 ± 18.36 gm)
(p ¼ 0.006). The mean resected weight was higher in iTURP group (14 gm)
than in pTURP group (10 gm). The pTURP group was more likely to reca-
theterization and the Foley home rate (FHR) was higher. The re-operation
rate was not signiﬁcant over two groups. There was no complication such
as transurethral resection (TUR) syndrome or perioperative death in either
group. There was no signiﬁcant difference of mortality over two groups.
Conclusion: TURP can be performed safely for relief of AUR in patients
with prostate cancer, no matter if the cancer was diagnosed before or after
surgery. The recatherization rate and FHR were higher in pTURP group,
which may be due to the palliative intent.
NDP034:
TWO RARE CASES OF PRIMARY MALIGNANAT SMALL CELL CARCINOMA
COMBINED WITH UROTHELIAL CELL CARCINOMA IN THE URETER AND
METAANALYSIS
Jhih-Cheng Wang 1,2, Li-Jing Ye 3, Zi-Ru Chen 3, Yu-Hsuan Kuo 4. 1Divisions
of Urology, Department of Surgery, Chi-Mei Medical Center, Tainan, Taiwan;2 Institution of Biomedical Engineering, National Cheng Kung University,
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Background: Extrapulmonary small cell carcinomas have been reported
in a variety of organs, and their incidence in the genitourinary tract is
second only to that in the gastrointestinal tract. To date, however, only a
few cases of small cell carcinoma of the ureter have been reported.
Because the extreme rarity of this combined type of carcinoma, its
clinical behavior, and effective treatment modalities have not yet been
studies well.
Cases Presentation: A 73-year-old man has a past history of prostate
adenocarcinoma, cT3aN0M0, s/p hormone therapy and radiotherapy and
regular followup at OPD. He presented with a two-month history of
painless gross hematuria. He had a smoking history of one pack (Ciga-
rettes, 20/pack) per day for over 30 years, but without having any respi-
ratory symptoms. After intravenous pyelography survey, left UPJ tumor
was suspected and diagnostic ureteronephroscopic biopsy revealed uro-
thelial carcinoma. Laparoscopic Nephroureterectomy done and pathologic
examination showed an SCC combined with a urothelial carcinoma in the
ureter.
Another patient is a 67 year-old female with a diabetes history, present
with intermittent painless gross hematuria. She also received diagnostic
ureteronephroscopic biopsy then laparoscopic nephroureterectomy with
bladder cuff done. The small cell carcinoma was diffusely positive for
neuron-speciﬁc enolase, and exhibited focal positivity for CD 56, syn-
aptophysin, chromogranin and cytokeratin 20. They were treated with
adjuvant chemotherapy, consistingof cisplatin and etopside, and has being
well, without evidence of tumor recurrence or metastasis in the 6 months
after surgery.
Conclusion: Small cell carcinoma of the ureter is rare. Combined uro-
thelial carcinoma with SCC is rarer. Although its clinical behavior and
diagnostic modalities have not been determined and it has yet to
be diagnosed immunohistopathologically, multimodality treatment
including surgery, chemotherapy and radiotherapy may improve patient
survival.LUTS
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FOR SMALLER WEIGHT TRANSURETHRAL RESECTION OF PROSTATE,
COMBINED TRANSURETHRAL INCISION OF BLADDER NECK IS AN
INDEPENDENT FACTOR FOR LESS URINARY RETENTION RATE. e A
NATION-WIDE DATABASE STUDY
Tzu-Chun Wei 1,2, Tzu-Ping Lin 1,2, Alex T.L. Lin 1,2, Hsiao-Jen Chung 1,2, Eric
YH. Huang 1,2, Kuang-Kuo Chen 1,2. 1Department of Urology, Taipei Veterans
General Hospital, Taiwan; 2Department of Urology, School of Medicine, and
Shu-Tien Urological Institute, National Yang Ming University, Taipei, Taiwan
Purpose: If the resection weight of transurethral resection of prostate
(TURP) is smaller, acute urinary retention (AUR) after the operationmay be
a complication of great concern, especially for those without Foley indw-
elled previously. However, whether combined transurethral incision of
bladder neck (TUIBN) may reduce AUR rates after the operation is still a
question. Therefore, this article is aimed to analyze AUR rates after smaller
resectionweight of TURP in Taiwan according to the claims of the National
Health Insurance (NHI) program.
Materials and Methods: From the NHI Research Database of Taiwan, we
applied for the all the claims of patients who ever visited urology clinic
during 2006 to 2010. We received all the records of both admission and
ambulatory clinics. In Taiwan, the NHI divides TURPs into four categories
according to the resection weight (<5g, S5~15g, S15~50g, and S50g,
respectively), and the ﬁrst group (<5g) was deﬁned as “smaller weight
TURP”. AUR was deﬁned as any kind of indwelling catheterization within 2
weeks after TURP with or without TUIBN. Patients younger than 40 years
old were excluded. Patients who received TUIBN or optic or otis ure-
throtomy within 1 year before TURP and 2 months after were excluded, as
well as those who had TURPs within 2 months between each surgery or
long admission period (14 dats) after TURP. Patients who had diagnosis of
